AARC Supports Pulmonary Fibrosis Bill
September 6, 2011
The AARC supports The Pulmonary Fibrosis Research Enhancement Act, which, if passed, will lead to better information on the deadly disease of pulmonary fibrosis.
The Pulmonary Fibrosis Research Enhancement Act has been introduced in both the House (HR 2505) by Representative Erik Paulsen of Minnesota and in the Senate (S 1350) by Christopher Coons of Delaware.
“The AARC hopes all respiratory therapists and pulmonary patients show their support for this bill,” said AARC President Karen Stewart. The AARC has activated a letter writing campaign through its Capitol Connection system.
The legislation would require a more focused effort by the Centers for Disease Control and Prevention and the National Institutes of Health to enhance research into the causes, better prevention, treatment, and possible cures for pulmonary fibrosis.
Every year, more than 48,000 Americans are diagnosed with pulmonary fibrosis and as many as 40,000 die every year from this debilitating and ultimately fatal disease. The prevalence of pulmonary fibrosis has increased more than 150 percent since 2001, and is expected to continue rising.